Cargando cotizaciones...
Previsión
| Comprar |
5 |
| Mantener |
0 |
| Vender |
0 |
Noticias Ir al feed de noticias
Bio-Path Holdings moves headquarters to Wyoming and creates Series S preferred shares
Bio-Path Holdings approved the move of its headquarters to Wyoming and filed an amendment to its charter to create a new class of Series S preferred shares consisting of 51 shares, each convertible into one common share and representing 1% of diluted voting power. The company also appointed Wendy M. Charles and Michael Hickey to a newly formed scientific advisory board; both received three-year contracts and were granted 100,000 stock options each with an exercise price of $0.06. The information comes from a filing with the SEC. » Más en de.investing.com
Datos financieros de la empresa
| (EUR) | junio de 2026 | |
|---|---|---|
| Ingresos | 0 | - |
| Beneficio bruto | 0 | 100,00 % |
| Beneficio neto | -2,31 M | 40,78 % |
| EBITDA | -821,01 mil | 78,60 % |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 147,93 mil € |
Número de acciones | 9,34 M |
Máximo/mínimo de 52 semanas | 0,11 € - 0,00861 € |
| Dividendos | No |
Beta | -0,50 |
Ratio P/E | -0,07 |
Ratio PEG | 0,00 |
Ratio P/B | -0,06 |
Ratio P/S | 0,00 |
Perfil de la empresa
| Nombre | BIO-PATH HLDGS IN.DL-,001 Aktie |
| CEO | Vikram Paul Grover |
| Empleados | 1 |
Descubrir activos
Los accionistas de BIO-PATH HLDGS IN.DL-,001 Aktie también invierten en los siguientes activos

